Loading...
Cariprazine: pharmacology and clinical management of psychiatric disorders
Antoun Reyad, Ayman Mishriky, Raafat
Antoun Reyad, Ayman
Mishriky, Raafat
Authors
Editors
Other contributors
Affiliation
Epub Date
Issue Date
2019-03-11
Submitted date
Alternative
Abstract
Cariprazine is a new atypical antipsychotic for schizophrenia and bipolar disorders 2 management. In this article, the role of cariprazine, a partial D2 and D3 receptors 3 agonist with a higher D3 affinity, in the management of psychiatric conditions is 4 illustrated. Cariprazine caused significant improvements in psychiatric scales such 5 as Positive and Negative Syndrome scale (PANSS), clinical global impressions 6 (CGI) and young mania rating scales (YMRS) and was associated with side effects 7 such as akathisia, restlessness and insomnia. These findings will guide psychiatrists 8 and pharmacists in their clinical role for supporting psychiatric patients care.
Citation
Antoun Reyad, A., Mishriky, R. (2019) 'Cariprazine: pharmacology and clinical management of psychiatric disorders', Psychiatric Annals, 49 (3) pp. 129-134
Publisher
Journal
Research Unit
PubMed ID
PubMed Central ID
Embedded videos
Additional Links
Type
Journal article
Language
en
Description
This is an accepted manuscript of an article published by Slack in Psychiatric Annals on 11/02/2019, available online: https://journals.healio.com/doi/10.3928/00485713-20190213-01
The accepted version of the publication may differ from the final published version.
Series/Report no.
ISSN
0048-5713
EISSN
ISBN
ISMN
Gov't Doc #
Sponsors
Rights
Attribution-NonCommercial-NoDerivs 3.0 United States